Efficacy of Ustekinumab in Palmoplantar Psoriasis
نویسندگان
چکیده
منابع مشابه
Cutaneous mucinosis in a patient taking ustekinumab for palmoplantar psoriasis.
Discrete papular lichen myxedematosus (DPLM), asubset of localized lichen myxedematosus, is a rarecutaneous mucinosis of unknown etiology. We reporta case of a 57-year-old woman with palmoplantarpsoriasis who developed DPLM 8 weeks after addingustekinumab to a long-term course of methotrexate.The patient had previously failed 2 prior tumor necrosisfactor (TNF) inhibitors, adalimumab and etanerc...
متن کامل[Good response of hyperkeratotic palmoplantar psoriasis to ustekinumab].
Although only a small area of the body is affected in palmoplantar psoriasis or psoriasis of the palms and soles, this condition causes considerable functional impairment due to hyperkeratosis, fissures, and erythema, and occasionally inflammation and pustules. These symptoms may seriously interfere with the patient’s quality of life and may be disabling. Moreover, the lack of a standard treatm...
متن کاملUstekinumab: differential use in psoriasis
Chronic plaque psoriasis is a systemic disease affecting over 3% of the population, and many patients are unsatisfied with their current treatment regimen. With advances in understanding of the pathophysiology of psoriasis, new therapeutic options are being developed. The newest of these agents, ustekinumab, offers patients rapid results and the convenience of four annual subcutaneous doses, wi...
متن کاملParadoxical Flare of Psoriasis after Ustekinumab Therapy
794 Ann Dermatol Received January 12, 2016, Revised September 24, 2016, Accepted for publication October 24, 2016 Corresponding author: Sik Haw, Department of Dermatology, Inje University Ilsan Paik Hospital, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea. Tel: 82-31-910-7224, Fax: 82-31-910-7227, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creati...
متن کاملThe Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review
INTRODUCTION Palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP) are diseases affecting the hands and/or feet that can cause marked physical discomfort and functional disability. The tumor necrosis factor-alpha antagonists adalimumab, etanercept, and infliximab, the interleukin (IL)-17A inhibitors ixekizumab and secukinumab, and the IL-23 or IL-12/IL-23 inhibitors guselkumab and ustek...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Dermatology
سال: 2010
ISSN: 1421-9832,1018-8665
DOI: 10.1159/000320961